The board shall grant a variance to a basic ambulance service licensee to carry and to administer beta agonist by metered dosed inhalation or nebulization, or both, premeasured subcutaneous epinephrine, sublingual nitroglycerin, or premeasured intramuscular or subcutaneous glucagon only if the licensee shows that:
each attendant who will administer the drug has satisfactorily completed training in the administration of the drug and the training has been approved by the licensee's medical director;
the licensee's medical director has developed or approved standing orders for the use of the drug;
continuing education or clinical training in the administration of the drug shall be provided at least annually to the licensee's attendants who are trained to administer the drug; and
at all times, at least one attendant on duty is trained in accordance with item A to administer the drug for which the ambulance service has been granted a variance.
Documentation of items A to E must be retained in the licensee's files.
In order to maintain a variance granted under subpart 7, the licensee's medical director shall, by the annual anniversary date of the approved variance:
certify in writing that each attendant has satisfactorily completed the required training and retained skill proficiency; and
certify in writing that, prior to allowing an attendant who was hired after the variance was granted to administer a drug specified in subpart 7, the attendant satisfactorily completed the required training under subpart 7, item A.
Documentation of items A to C shall be retained in the licensee's files.
A basic ambulance service shall not be granted a variance for the establishment of intravenous therapy involving the use of drugs other than solutions for intravenous infusion.
L 1987 c 209 s 39; 14 SR 519; L 1996 c 324 s 6; 22 SR 1877; L 1999 c 245 art 9 s 66
December 12, 2012
Official Publication of the State of Minnesota
Revisor of Statutes